Renovaro Issues Shareholder Letter and Provides Corporate Update
07 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro Issues Shareholder Letter and Provides Corporate Update
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
07 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
06 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
30 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
23 déc. 2024 09h00 HE
|
Renovaro Inc
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
Renovaro Regains Compliance with NASDAQ Listing Requirement
20 déc. 2024 15h40 HE
|
Renovaro Inc
Renovaro Regains Compliance with NASDAQ Listing Requirement
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
20 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
Renovaro Issues Shareholder Letter and Provides Corporate Update
04 nov. 2024 08h31 HE
|
Renovaro Inc
Renovaro Issues Shareholder Letter and Provides Corporate Update
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
17 oct. 2024 09h15 HE
|
Renovaro Inc
AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the...
Renovaro Announces Strategic Restructuring and Leadership Transition
16 oct. 2024 09h28 HE
|
Renovaro Inc
Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member SlateRealignment of Resources to Optimize and Commercialize...